Continuing clozapine with granulocyte colony-stimulating factor in patients with neutropenia

Therapeutic Advances in Psychopharmacology

Volumn 3, Issue 5, 2013, Pages 266-271

  Khan, al Aditya ^a   Harvey, Jake ^b   Sengupta, Samrat ^c  

^a Bracton Centre   (United Kingdom)

^b WEST LONDON MENTAL HEALTH NHS TRUST   (United Kingdom)

^c BROADMOOR HOSPITAL   (United Kingdom)

Author keywords

clozapine; clozapine induced neutropenia; granulocyte colony stimulating factor

Indexed keywords

ANTIBIOTIC AGENT; CLOZAPINE; GRANULOCYTE COLONY STIMULATING FACTOR; LITHIUM; NEUROLEPTIC AGENT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGGRESSION; AGRANULOCYTOSIS; ANTISOCIAL PERSONALITY DISORDER; ARTICLE; ASSAULT; AUDITORY HALLUCINATION; CASE REPORT; CHEST INFECTION; CRIME; DRUG DOSE INCREASE; DRUG MONITORING; DRUG RECHALLENGE; DRUG WITHDRAWAL; FANTASY; GRANDIOSE DELUSION; HUMAN; MALE; MENTAL DETERIORATION; MENTAL HOSPITAL; NARCISSISM; NEUTROPENIA; NEUTROPHIL COUNT; PARANOIA; PARANOID SCHIZOPHRENIA; PATIENT COMPLIANCE; PERSECUTORY DELUSION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCHIZOPHRENIA; SIDE EFFECT; TREATMENT DURATION; UNITED KINGDOM; VIOLENCE; WEIGHT GAIN;

EID: 84997860338     PISSN: 20451253     EISSN: 20451261     Source Type: Journal    
DOI: 10.1177/2045125313476877     Document Type: Article

References (29)

1. Alvir J. Lieberman J. Safferman A. Schwimmer J. Schaaf J. (1993) Clozapine induced agranulocytosis – incidence and risk factors in the United States. N Engl J Med 329: 162–167.
2. Atkin K. Kendall F. Gould D. Freeman H. Liberman J. O’Sullivan D. (1996) Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland. Br J Psychiatry 169: 483–488.
3. Beer M. Khan A. Ratnajothy K. (2006) The effect of clozapine on adverse incidents in a low secure challenging behaviour unit. J Psychiatr Intensive Care 2: 65–70.
4. Buckley P. Bartell J. Donenwirth K. Lee S. Torigoe F. Schulz S. (1995) Violence and schizophrenia: clozapine as a specific antiaggressive agent. Bull Am Acad Psychiatry Law 23: 607–611.
5. Chin-Yee I. Bezchlibnyk-Butler K. Wong L. (1996) Use of cytokines in clozapine-induced agranulocytosis. Can J Psychiatry 41: 280–284.
6. Conus P. Nanzer N. Baumann P. (2001) An alternative to interruption of treatment in recurrent clozapine induced severe neutropenia. Br J Psychiatry 179: 180–180.
7. Duggan A. Warner J. Knapp M. Kwewin R. (2003) Modelling the impact of clozapine on suicide in patients with treatment-resistant schizophrenia in the UK. Br J Psychiatry 182: 505–508.
8. Dunk L. (2006) Rechallenge with clozapine following leucopenia or neutropenia during previous therapy. Br J Psychiatry 188: 255–263.
9. Gerson S. Lieberman J. Friedenberg W. Lee D. Marx J. Meltzer H. (1991) Polypharmacy in fatal clozapine-associated agranulocytosis. Lancet 338: 262–263.
10. Glazer W. Dickson R. (1998) Clozapine reduces violence and persistent aggression in schizophrenia. J Clin Psychiatry 59: 8–14.
11. Hagg S. Rosenius S. Spigset O. (2003) Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis. Int Clin Psychopharmacol 18: 173–174.
12. Hector R. (1998) The use of clozapine in the treatment of aggressive schizophrenia. Can J Psychiatry 43: 466–472.
13. Joffe G. Eskelinen S. Salias E. (2009) Add-on filgrastim during clozapine rechallenge in patients with a history of clozapine-related granulocytopenia/agranulocytosis. Am J Psychiatry 166: 236–236.
14. Jones E. Boylard A. Dale D. (1993) Quality of life of patients with severe neutropenia receiving long-term treatment with granulocyte colony-stimulating factor. JAMA 270: 1132–1133.
15. Kane J. Honigfield G. Singer J. (1988) Clozapine for the treatment-resistant schizophrenic: a double blind comparison with chlorpromazine. Arch Gen Psychiatry 45: 789–796.
16. Kilian J. Kerr K. Lawrence C. Celermajer D. (1999) Myocarditis and cardiomyopathy associated with clozapine. Lancet 354: 1941–1945.
17. Lewis S. Barnes T. Davies L. Murray R. Dunn G. Hayhurst K. et al. (2006) Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophr Bull 32: 715–723.
18. Majczenko T. Stewart J. (2008) Failure of filgrastim to prevent severe clozapine-induced agranulocytosis. South Med J 101: 639–640.
19. Mathewson K. Lindenmayer J. (2007) Clozapine and granulocyte colony-stimulating factor: potential for long-term combination treatment for clozapine-induced neutropenia. J Clin Psychopharmacol 27: 714–715.
20. McEvoy J. Lieberman J. Stroup T. Davis S. Meltzer H. Rosenheck R. et al. (2006) Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. Am J Psychiatry 163: 600–610.
21. National Institute for Health and Clinical Excellence (2009) Schizophrenia: core interventions in the treatment and management of schizophrenia in adults in primary and secondary care (update). Available at: http://www.nice.org.uk/CG82 (accessed 18 January 2013).
22. Rabinowitz J. Avnon M. Rosenberg V. (1996) Effect of clozapine on physical and verbal aggression. Schizophr Res 22: 249–255.
23. Rajagopal G. Graham J. Haut F. (2007) Prevention of clozapine-induced granulocytopenia/ agranulocytosis with granulocyte-colony stimulating factor (G-CSF) in an intellectually disabled patient with schizophrenia. J Intellect Disabil Res 51: 82–85.
24. Sperner-unterweger B. Czeipek I. Gaggl S. Geissler D. Speil G. Fleischhacker W. (1998) Treatment of severe clozapine-induced neutropenia with granulocyte colony-stimulating factor (G-CSF). Br J Psychiatry 171: 81–84.
25. Spivak B. Mester R. Wittenberg N. Maman Z. Weizman A. (1997) Reduction of aggressiveness and impulsiveness during clozapine treatment in chronic neurolepticresistant schizophrenic patients. Clin Neuropharmacol 20: 442–446.
26. Valevski A. Modai I. Lahav M. Weizman A. (1993) Clozapine–lithium combined treatment and agranulocytosis. Int Clin Psychopharmacol 8: 63–65.
27. Volovka J. (1999) The effects of clozapine on aggression and substance abuse in schizophrenic patients. J Clin Psychiatry 60: 43–46.
28. Volovka J. Czobor P. Nolan K. Sheitman B. Lindenmayer J. Citrome L. et al. (2004) Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol. J Clin Psychopharmacol 24: 225–228.
29. Whiskey E. Taylor D. (2007) Restricting clozapine after neutropenia: evaluating the possibilities and practicalities. CNS Drugs 21: 25–35.